ECHS1
Enoyl-CoA hydratase, mitochondrial
Also known as: ECHM_HUMAN, SCEH
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30084
- Gene
- ECHS1
- Ensembl
- ENSG00000127884
- Chromosome
- 10
- Canonical length
- 290 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
The protein encoded by this gene functions in the second step of the mitochondrial fatty acid beta-oxidation pathway. It catalyzes the hydration of 2-trans-enoyl-coenzyme A (CoA) intermediates to L-3-hydroxyacyl-CoAs. The gene product is a member of the hydratase/isomerase superfamily. It localizes to the mitochondrial matrix. Transcript variants utilizing alternative transcription initiation sites have been described in the literature. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>P30084|ECHS1
1 MAALRVLLSC VRGPLRPPVR CPAWRPFASG ANFEYIIAEK RGKNNTVGLI QLNRPKALNA
61 LCDGLIDELN QALKTFEEDP AVGAIVLTGG DKAFAAGADI KEMQNLSFQD CYSSKFLKHW
121 DHLTQVKKPV IAAVNGYAFG GGCELAMMCD IIYAGEKAQF AQPEILIGTI PGAGGTQRLT
181 RAVGKSLAME MVLTGDRISA QDAKQAGLVS KICPVETLVE EAIQCAEKIA SNSKIVVAMA
241 KESVNAAFEM TLTEGSKLEK KLFYSTFATD DRKEGMTAFV EKRKANFKDQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ECHS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 1,286 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,286 nTPM
- kidney: 511 nTPM
- adipose tissue: 284 nTPM
- heart muscle: 281 nTPM
- skeletal muscle: 276 nTPM
- tongue: 253 nTPM
Single-cell type
- hepatocytes: 1,716 nCPM
- esophageal apical cells: 621 nCPM
- cytotrophoblasts: 583 nCPM
- esophageal suprabasal cells: 449 nCPM
- enterocytes: 416 nCPM
- enteric transient amplifying cells: 337 nCPM
Immune cell
- myeloid DC: 243 nTPM
- total PBMC: 233 nTPM
- intermediate monocyte: 212 nTPM
- classical monocyte: 185 nTPM
- memory B-cell: 179 nTPM
- non-classical monocyte: 169 nTPM
Brain region
- choroid plexus: 119 nTPM
- thalamus: 89 nTPM
- white matter: 88 nTPM
- hippocampal formation: 83 nTPM
- cerebellum: 80 nTPM
- spinal cord: 79 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ECHS1.
Disease | AllUniProt
Conditions ECHS1 is implicated in, by any mechanism.
- Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) MIM:616277
Disease | GeneticClinVar
63 pathogenic / likely-pathogenic of 405 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency
- ECHS1-related disorder
- Leigh syndrome
- Inborn genetic diseases
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.86
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- (2E)-butenoyl-CoA hydratase activity
- delta(3)-delta(2)-enoyl-CoA isomerase activity
- enoyl-CoA hydratase activity
- 3-hydroxypropionyl-CoA dehydratase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ECHS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ECHS1 as an antibody target. Whether an autoantibody or antibody against ECHS1 could matter depends on whether native ECHS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ECHS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ECHS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...